## APH: Amphenol Corporation - XLK: Technology

### Executive Summary

VALUE thesis: PEG 1.11 indicates fundamental undervaluation. Quality metrics strong (ROE 35%, ROA 14%). Consistent execution (4/4 quarters beat estimates). Caution: momentum weakening (-3.3% MRS).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($121.18)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 2
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Effective Execution Lifted Amphenol Corp (AMP) in Q3**
- Source: Insider Monkey | 20251215T081200 | Somewhat-Bullish | Relevance: 94%
- TimesSquare Capital Management's "U.S. Focus Growth Strategy" Q3 2025 investor letter highlighted Amphenol Corporation (NYSE: APH) for its strong performance driven by effective execution. Despite macroeconomic challenges, Amphenol's Q3 sales were up 53% in US dollars, and its stock gained 71.52% over the last 52 weeks. The company's growth was also boosted by rising data center spending expectations due to accelerating AI adoption.

**2. Eaton (ETN) Stock After Hours Dec. 12, 2025: Why Shares Fell, What Analysts Forecast, and What to Watch Before the Next Market Open**
- Source: ts2.tech | 20251213T025627 | Somewhat-Bearish | Relevance: 68%
- Eaton (ETN) stock fell 5.25% on December 12, 2025, primarily due to a broader market decline and sector-specific selling pressure, with a minor rebound in after-hours trading. Key factors influencing investor sentiment include ongoing discussions about AI infrastructure's reliance on electrical grids and a legal headline concerning a potential $14 billion subsidiary transfer for tax purposes. Analysts maintain a generally constructive outlook with an average 12-month price target around $400.05, emphasizing Eaton's role in electrification and data center infrastructure despite short-term uncertainties.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 7 ($17.10M) |
| Sells | 8 ($29.86M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 43.8% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 4 |

**Top Holders:**
- Vanguard Group Inc: 10.2% (-10.9%)
- Blackrock Inc.: 8.2% (+6.7%)
- FMR, LLC: 8.1% (-8.1%)
- State Street Corpora: 4.6% (+1.2%)
- Price (T.Rowe) Assoc: 3.6% (+5.8%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-3.3% 5d) with bearish MACD, trend may be turning.
2. Heavy insider selling: $30M sold (8 transactions in 90 days).
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.11 suggests fair value with growth premium. Quality metrics strong (ROE 35%, ROA 14%, margin 18%). Balance sheet: strong liquidity (2.1x), $1.2B free cash flow. Institutional flow bullish (5 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $159.0B |
| Beta | 1.19 |
| 52W Range | $56.45 - $144.37 |
| Short Interest | 1.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.11 |
| Forward P/E | 32.5 |
| Current P/E | 39.3 |
| YoY Growth | 21.0% |
| EPS Direction | RISING |

### Technicals

MRS_20 deteriorating from -1.3% to -4.7% (-3.3% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 8.7pp (needs >4.0% for momentum thesis). AM_20 at -4.9% indicates price below own 20MA trend. Underperforming sector by 4.2pp, stock-specific weakness. Long-term uptrend intact (above SMA200 at 1.26x) but short-term weakness (below SMA20). MACD histogram bearish (-1.21), momentum weakening. OFD pattern: -DUN (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -4.67% (CS: 10) | Weak |
| RSI_14 | 39.1 | Neutral |
| MACD Histogram | -1.21 | Bearish |
| vs SMA20 | 0.951x | Below |
| vs SMA50 | 0.967x | Below |
| vs SMA200 | 1.265x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $129.90
- **Stop Loss:** $121.18 (6.7% risk)
- **Target:** $147.34 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 114
- **Position Value:** $14,808.60
- **Portfolio %:** 14.81%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at moderate levels (16.5) with elevated put/call ratio suggesting cautious positioning, while normal yield curve and stable breadth indicate no systemic stress. Focus on selective opportunities with defensive positioning.*

### Earnings

**Next:** 2026-01-28 (Est: $0.94)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.80 | $0.93 | +16.5% |
| 2025Q2 | $0.67 | $0.81 | +21.7% |
| 2025Q1 | $0.52 | $0.63 | +21.0% |
| 2024Q4 | $0.50 | $0.55 | +9.2% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*